Summary
In the Munich Blood Pressure Study (MBS), a cross-sectional study (MBS I) with follow-up (MBS II) of a random sample of 3,198 citizens aged 30–69 (response rate, 69.3%), treatment and control of hypertension were examined.
Of the actual hypertensives 59% (221) in MBS II (373) were on drug treatment and about two-thirds (150) of those being treated had controlled blood pressure (BP). Women's BP was better controlled than men's.
Of the 221 treated hypertensives 85% (188) received types of drugs or drug combinations which were in accordance with the recommendations of the German Hypertension League. However, this did not apply to the prescribed dosages of the various drugs. Of the treated hypertensives 52% were either on a diuretic, on a beta-blocker, or on a combination of both drugs. Rauwolfia alkaloids combined with a diuretic were given to 27%.
In 79% of the participants who had received a beta-blocker either alone or in combination with other antihypertensive agents and who still had high BP values, the prescribed beta-blocker dosage was below the recommended daily dose. Fatigue was the most frequently reported symptom, possibly attributable to antihypertensive drug treatment.
Electrocardiographic signs of left ventricular hypertrophy were found less frequently in controlled hypertensives, in comparison to treated but uncontrolled hypertensives or untreated hypertensives.
Similar content being viewed by others
Abbreviations
- AV:
-
Atrioventricular
- BMI:
-
Body mass index
- BP:
-
Blood pressure
- DBP:
-
Diastolic blood pressure
- GKV:
-
Gesetzliche Krankenversicherung
- ISH:
-
International society for hypertension
- LVH:
-
Left ventricular hypertrophy
- MBS:
-
Munich blood pressure study
- NHANES:
-
National health and nutrition examination survey
- SBP:
-
Systolic blood pressure
References
Bray GA (1978) Definition, measurement and classification of the syndromes of obesity. Int J Obesity 2:99–112
Breithaupt H (1983) Behandlung der Hypertonie. Schattauer, Stuttgart New York
Capella D, Porta M, Laporte JR (1983) Utilization of anti-hypertensive drugs in certain European countries. Eur J Clin Pharmacol 25:431–435
Connolly DC, Elveback LR, Oxman HA (1983) Coronary heart disease in residents of Rochester, Minnesota, 1950–1975. III. Effects of hypertension and its treatment on survival of patients with coronary artery disease. Mayo Clin Proc 58:249–254
Der pharmazeutische Markt Deutschlands — DPM 1981. Institut für medizinische Statistik — IMS GmbH, Frankfurt/Main
Deutsche Liga zur Bekämpfung des hohen Blutdruckes eV (1980) Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle, 3rd edn
Drayer JIM, Weber MA, Gardin JM, Lipson JL (1983) Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. Am J Cardiol 75:116–120
Dreslinski GR (1983) Identification of left ventricular hypertrophy: chest roentgenography, echocardiography, and electrocardiography. Am J Cardiol 75:47–50
Folsom AR, Luepker RV, Gillum RF, Jacobs DR, Prineas RJ, Taylor HL, Blackburn H (1983) Improvement in hypertension detection and control from 1973–1974 to 1980–1981. The Minnesota Heart Survey Experience. JAMA 25:916–921
Frishman W, Silverman R (1979) Clinical pharmacology of the new betaadrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications. Am Heart J 98:119–131
GKV-Arzneimittelindex 1982 (1983) Wissenschaftliches Institut der Ortskrankenkassen (WIdO), Bonn
Gross F (1981) Drug utilization — theory und practice. The present situation in the Federal Republic of Germany. Eur J Clin Pharmacol 19:387–394
Guidelines for the treatment of mild hypertension (1983) Memorandum from a WHO/ISH meeting. Bull WHO 61(1):53–56
Hypertension detection and follow-up program cooperative group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242:2562–2571
Hypertension detection and follow-up program cooperative group (1979) Five-year findings of the hypertension detection and follow-up program. II. Mortality by race, sex and age. JAMA 242:2572–2577
Hypertension detection and follow-up program cooperative group (1982) Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 247:633–638
Hypertension detection and follow-up program cooperative group (1982) The effect of treatment on mortality in “mild” hypertension. N Engl J Med 307:976–980
Kannel WB (1983) Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Cardiol 75:4–11
Keil U, Döring A, Stieber J (1983) Community studies in the Federal Republic of Germany. In: Gross F, Strasser T (eds) mild hypertension: recent advances. Raven Press, New York, pp 63–83
Kirkendall WM, Feinleib M, Freis E, Mark AL (1981) Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA postgraduate education committee. Hypertension 3:510A-519A
Lenfant C, Roccella EJ (1984) Trends in hypertension control in the United States. Chest 86:459–462
Management committee (1980) The Australien therapeutic trial in mild hypertension. Lancet I:1261–1267
Materson BJ, Oster JR, Michael UF (1978) Dose response to chlorthalidone in patients with mild hypertension. Clin Pharmacol Ther 24:192–196
Pöppl SJ, Herrmann G, Luft R (1982) Experiences in developing of a stand-alone ECG acquisition and analysis system. Proceedings MEDCOMP 82, 1st IEEE Computer Society International Conference on Medical Computer Science/Computational Medicine, Philadelphia/USA
Romhilt DW, Estes EH (1968) A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 6:752–758
Stieber J, Döring A, Keil U (1982) Häufigkeit, Bekanntheits- und Behandlungsgrad der Hypertonie in einer Großstadtbevölkerung. Münch Med Wochenschr 124:747–752
Tarazi RC (1983) Regression of left ventricular hypertrophy by medical treatment: present status and possible implications. Am J Cardiol 75:80–86
Tweeddale MG, Ogilvie RI, Ruedy J (1977) Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther 22:519–524
Verschreibungsindex für Pharmazeutika (1980) — VIP, IV. Quartal 1980. Institut für medizinische Statistik, Frankfurt/Main
Veterans administration cooperative study group on antihypertensive agents (1967) Effects of treatment on mortality in hypertension. I. Results in patients with diastolic blood pressure average 115 through 129 mm Hg. JAMA 202:1028–1034
Veterans administration cooperative study group on antihypertensive agents (1970) Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 231:1143–1152
Waal-Manning HJ (1976) Hypertension: which beta-blocker? Drugs 12:412–441
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koenig, W., Keil, U., Perz, S. et al. Treatment of hypertension. Klin Wochenschr 64, 1229–1236 (1986). https://doi.org/10.1007/BF01734464
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01734464